D C Tomlinson Selected Research

Cystectomy

1/2016

Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D C Tomlinson Research Topics

Disease

5	Neoplasms (Cancer) 01/2020 - 06/2012
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016 - 08/2007
3	Carcinoma (Carcinomatosis) 01/2011 - 08/2007
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Heart Diseases (Heart Disease) 01/2016
1	Lymphoma (Lymphomas) 01/2014
1	Breast Neoplasms (Breast Cancer) 06/2012

Drug/Important Bio-Agent (IBA)

4	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2016 - 08/2007
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 06/2012 - 01/2011
1	OligonucleotidesIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Mitogen-Activated Protein KinasesIBA 06/2012
1	Fibroblast Growth Factor 1 (FGF-1)IBA 06/2012
1	Estrogen ReceptorsIBA 06/2012
1	Tamoxifen FDA LinkGeneric 06/2012
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 06/2012
1	Phosphatidylinositols (Phosphatidylinositol)IBA 06/2012
1	Small Interfering RNA (siRNA)IBA 08/2007

Therapy/Procedure

4	Therapeutics 01/2016 - 09/2007
1	Cystectomy 01/2016